{"id":871,"date":"2020-11-26T12:49:34","date_gmt":"2020-11-26T09:49:34","guid":{"rendered":"https:\/\/systempharm.com.ua\/?p=871"},"modified":"2024-10-02T17:25:18","modified_gmt":"2024-10-02T14:25:18","slug":"publikaciya-v-zhurnali-zdorov-ya-cholovika-vipusk-3-listopad-2020","status":"publish","type":"post","link":"https:\/\/dev.systempharm.com.ua\/en\/publikaciya-v-zhurnali-zdorov-ya-cholovika-vipusk-3-listopad-2020\/","title":{"rendered":"PUBLICATION IN THE MEN&#8217;S HEALTH MAGAZINE (ISSUE #3, NOVEMBER 2020)"},"content":{"rendered":"<p>Topic: &#8220;Evaluation of the effectiveness of the drug PHARMAPROST in monotherapy in patients with a combination of grade I benign prostatic hyperplasia and chronic abacterial prostatitis&#8221;<\/p>\n<p>In this article, the author conducts research aimed at studying PHARMAPROST as monotherapy.<\/p>\n<p>The results are impressive! The obtained data confirm the clinical efficacy of PHARMAPROST in patients with a combination of grade I BPH and chronic abacterial prostatitis (NIH USA, category IIIa CP\/CPPS &#8211; chronic prostatitis\/chronic pelvic pain syndrome with signs of inflammation). High clinical (89.6\u201391.7%) efficiency of PHARMAPROST application has been proven. The treatment was accompanied by good tolerance and minimal side effects.<\/p>\n<p>You can read the article below and even save it to yourself.<\/p>\n<p>\u2b50\ufe0f\u2b50\ufe0f\u2b50\ufe0f <a href=\"https:\/\/dev.systempharm.com.ua\/wp-content\/uploads\/2020\/11\/PHARMARPOST-ARTICLE.pdf\">PHARMARPOST ARTICLE<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Topic: &#8220;Evaluation of the effectiveness of the drug PHARMAPROST in monotherapy in patients with a combination of grade I benign prostatic hyperplasia and chronic abacterial prostatitis&#8221; In this article, the author conducts research aimed at studying PHARMAPROST as monotherapy. The results are impressive! The obtained data confirm the clinical efficacy of PHARMAPROST in patients with [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":872,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-871","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1"],"_links":{"self":[{"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/posts\/871"}],"collection":[{"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/comments?post=871"}],"version-history":[{"count":5,"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/posts\/871\/revisions"}],"predecessor-version":[{"id":888,"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/posts\/871\/revisions\/888"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/media\/872"}],"wp:attachment":[{"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/media?parent=871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/categories?post=871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev.systempharm.com.ua\/en\/wp-json\/wp\/v2\/tags?post=871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}